IDEAYA Biosciences (IDYA) Cash from Investing Activities (2018 - 2026)

IDEAYA Biosciences has disclosed Cash from Investing Activities across 9 years of filings, most recently posting $119.0 million for Q1 2026.

• Cash from Investing Activities for Q1 2026 came in at $119.0 million, up 49.03% year-over-year; the trailing twelve-month figure through Mar 2026 was $109.1 million (up 258.66% YoY), and the FY2025 annual result was $70.0 million, up 113.92% from the prior year.
• Cash from Investing Activities came in at $119.0 million for Q1 2026 at IDEAYA Biosciences, up from -$97.5 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $119.0 million in Q1 2026 to a low of -$354.0 million in Q1 2024.
• The 5-year median for Cash from Investing Activities is -$10.3 million (2022), against an average of -$29.7 million.
• Across the five-year window, Cash from Investing Activities tumbled 2388.14% in 2022 and surged 374.83% in 2023, its largest moves.
• IDEAYA Biosciences' Cash from Investing Activities stood at -$10.3 million in 2022, then tumbled by 989.36% to -$111.9 million in 2023, then sank by 76.08% to -$197.1 million in 2024, then jumped by 50.52% to -$97.5 million in 2025, then surged by 221.97% to $119.0 million in 2026.
• The last three Cash from Investing Activities figures came in at $119.0 million (Q1 2026), -$97.5 million (Q4 2025), and $41.8 million (Q3 2025), per Business Quant data.